About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials | 6,410 Studies Recruiting

Clinical TrialsColorectal Cancer

Colorectal Cancer Clinical Trials

Browse 6,410 clinical trials for colorectal cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 401-420 of 6,410 trials

CompletedRetrospective Analysis of Colorectal Cancer Screening ResultsThe purpose of this study is to retrospectively analyze colorectal cancer screening data of 40-74 year old population in Shipai Town, Dongguan City.NCT05374369·Dongguan, Guangdong UnknownCetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal CancerThis is an open-label, multicenter, randomized study to be conducted in Chinese patients with RAS and BRAF wild-type mCRC.NCT04262635·Guangzhou, Guangdong TerminatedPre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to FluoropyrimidinesThe aim of this study is to demonstrate the medical and financial benefit of pre-therapeutic screening of DPD deficiency for predicting toxicity to fluoropyrimidines.NCT01547923·Angers and 24 others

Related Searches

colon cancertrials rectal cancertrials

Data from ClinicalTrials.govTerms

CompletedNon-invasive Identification of Colorectal Cancer and Adenomas in Early StagesThe NICE study is a prospective, multi-site study to train and validate a blood-based, glycoproteomic test for the early detection of advanced adenoma and colorectal cancer by…NCT05445570·Mobile, Alabama and 11 others

CompletedA Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or RectumThis expanded access study will assess the efficacy and safety of intravenous (IV) bevacizumab in combination with chemotherapy regimens as first-line treatment of metastatic…NCT02582970·Chai Yi and 7 others

CompletedMailed Reminders Plus Fecal Immunochemical TestingPurpose: The investigators propose to test the effectiveness, feasibility, and cost-effectiveness of a mailed reminder with and without FIT kits in a population of Medicaid…NCT03176082

UnknownMetastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation ProjectInvestigator initiated multi-institutional retrospective review of clinical and radiographic outcomes after 90Y resin microsphere radioembolization for metastatic colorectal liver…NCT01815879·Nashville, Tennessee

TerminatedCapecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal AdenocarcinomaRATIONALE: Drugs used in chemotherapy, such as capecitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00625183·Buffalo, New York

UnknownRALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)Raltitrexed is an inhibitor of thymidylate synthase.As a folate antimetabolite drug, raltitrexed has been used in treatment of colorectal cancer(CRC) since 1998, and also used in…NCT03813641·Shenzhen, Guangdong

Not yet recruitingA Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal CancerThis is a single-arm, open-label clinical trial designed to evaluate the efficacy and safety of irinotecan liposome (II), 5-FU/LV in combination with bevacizumab for the treatment…NCT07123441·Shanghai, Shanghai Municipality

CompletedColorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus ColonoscopyThis study is aimed: 1) to compare the accuracy of colonoscopy vs immunochemical faecal occult blood test (iFOBT) and colonoscopy when positive for colorectal cancer (CRC)…NCT01075633·Santa Cruz de Tenerife, Spain

TerminatedGemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine and oxaliplatin work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00276861·Miami, Florida

CompletedImproving the Frequency of Colonoscopy in Patients With a Previous Colorectal PolypRATIONALE: Receiving a reminder letter from their doctor may increase the frequency of colonoscopy in patients who have had a colorectal polyp removed.NCT00397969·Boston, Massachusetts and 1 other

CompletedColorectal Cancer Screening in Chinese Rural CommunitiesColorectal cancer (CRC) is one of the most common malignant neoplasms significantly impacting population health and longevity.NCT07180303·Liyang, Jiangsu

Not yet recruitingNudging Preventive Screening Via Message Framing and BundlingThis study is a randomized controlled field experiment embedded in the medical institution Early Diagnosis Program in Chile.NCT07644910

TerminatedOSI-906 and Irinotecan in Patients With Advanced CancerThis study plans to learn more about an investigational drug called OSI-906. OSI-906 is being looked at to see if it could be a treatment for advanced cancer.NCT01016860·Aurora, Colorado

UnknownEffect of an Advanced Notification Letter on Screening Colonoscopy ParticipationParticipation in a primary screening colonoscopy programs remains low.NCT02188927·Warsaw, Mazovian

Active not recruitingA Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsThe purpose of this study is to test the safety and tolerability of HFB200603 as a single agent and in combination with tislelizumab in patients with advanced cancers.NCT05789069·Los Angeles, California and 10 others

CompletedChromogranin A as Blood Marker in Cancer PatientsGastroentero-pancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of neoplasms that arise from enterochromaffin cells of the gastrointestinal (GI) tract and…NCT03817866·Palo Alto, California and 3 others

CompletedA Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been CompletedThe purpose of this study is to enable participants, currently receiving regorafenib in a Bayer-sponsored clinical trial, to continue treatment after their respective study has…NCT03890731·Tampa, Florida and 5 others

PreviousPage 21 of 321Next